| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 05/16/2013 | WO2013068917A1 Processes for the production of a lactone statin intermediate by enzymatic oxidation |
| 05/15/2013 | CN103108861A Neuraminidase inhibitors |
| 05/14/2013 | US8440608 Beta-substituted tetrandropyrana (on) s and method for the synthesis and the use thereof |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | WO2013063679A1 Use of neul sialidase inhibitors in the treatment of cancer |
| 05/10/2013 | CA2858246A1 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/09/2013 | US20130116449 Single-reactor process for producing liquid-phase organic compounds from biomass |
| 05/08/2013 | EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 05/08/2013 | CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/08/2013 | CN103086849A Liquid crystal compound and composition thereof |
| 05/02/2013 | WO2013063127A1 Cyclohexylamines |
| 05/02/2013 | WO2013061919A1 Novel compound and method for producing same |
| 05/02/2013 | WO2013060805A1 Method for producing cis-rose oxide |
| 05/02/2013 | WO2013060653A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | US20130109867 Process for the preparation of cis-rose oxide |
| 05/02/2013 | US20130109718 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | CA2853279A1 Cyclohexylamines |
| 05/02/2013 | CA2851062A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/01/2013 | EP2586775A1 Method for producing cis-rose oxide |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | US20130101667 Cyclohexylamines |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/24/2013 | CN103068808A Agrochemical adjuvants and formulations |
| 04/24/2013 | CN103058974A Natural compound and preparation method and application thereof |
| 04/24/2013 | CN103058973A Preparation method for delta-decalactone |
| 04/24/2013 | CN103058972A Phenyl C-glucoside derivatives containing cyclohexane structure as well as preparation method and application thereof |
| 04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
| 04/18/2013 | WO2013055577A1 Selective androgen receptor modulators |
| 04/18/2013 | WO2013054366A1 A. process for the preparation of am5noacrylic acid derivatsves |
| 04/18/2013 | WO2013028570A3 Meta-substituted biphenyl peripherally restricted faah inhibitors |
| 04/18/2013 | CA2847889A1 Selective androgen receptor modulators |
| 04/17/2013 | EP2580225A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 04/17/2013 | EP2580202A1 Process for the preparation and isolation of 2-substituted tetrahydropyranols |
| 04/17/2013 | CN103052646A Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
| 04/17/2013 | CN103052631A Methods and compounds for treating paramyxoviridae virus infections |
| 04/17/2013 | CN103044376A Technology for separating pyrone from Phellinus |
| 04/17/2013 | CN103044375A Dihydro-pyranone compound and preparation method and medical application thereof |
| 04/17/2013 | CN103044374A Synthesis method of delta-dodecalactone |
| 04/17/2013 | CN103040832A Application of substituted cyanobenzene in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040813A Application of p-chloroaniline substituted pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040812A Application of substituted pyranone compound in preparation of fungal growth inhibiting drugs |
| 04/17/2013 | CN103040811A Application of p-methoxyphenylamino pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040810A Preparation and medical application of substituted tetrahydro-pyran-4-yl ester compound |
| 04/17/2013 | CN103040809A Preparation and medical application of substituted tetrahydro-pyranyl ester compound |
| 04/17/2013 | CN103040808A Application of phenylpropionic-acid-substituted tetrahydro-pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN101589034B Pyran derivatives, process of preparation and use thereof in perfumery and flavouring |
| 04/17/2013 | CN101006092B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same |
| 04/16/2013 | US8420833 Producing biofuels using polyketide synthases |
| 04/11/2013 | WO2013052700A1 Novel sulfonamides |
| 04/11/2013 | WO2012172143A3 Alkyl gallate derivatives as antioxidants and surfactants |
| 04/10/2013 | EP2576534A1 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| 04/10/2013 | EP2576533A1 Method for the production of tetrahydropyranols substituted in the 2-position |
| 04/10/2013 | EP2576506A1 Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran-dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde |
| 04/10/2013 | CN103030633A Process and intermediate compounds useful in the preparation of statins |
| 04/10/2013 | CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/10/2013 | CN101969944B Pharmaceutical composition for treatment of fatty liver diseases |
| 04/10/2013 | CN101528723B Renin inhibitors |
| 04/10/2013 | CN101195599B 2,4,6-phenyl substituted cyclic ketoenols |
| 04/04/2013 | WO2012137982A3 Sulfonamide derivative and use thereof |
| 04/04/2013 | US20130085283 Geranylgeranylacetone derivatives |
| 04/03/2013 | CN103012771A Acid-sensitive splitting-decomposable connecting unit and application thereof |
| 04/03/2013 | CN103012344A Method of recovering lovastatin from lovastatin crystal mother liquor |
| 04/03/2013 | CN101575287B Synthesizing method of simvastatin ammonium salt, midbody used thereby and preparation method thereof |
| 04/02/2013 | US8410293 Process for the preparation of cyclic enol ethers |
| 04/02/2013 | US8409574 Taxane analogs for the treatment of brain cancer |
| 04/02/2013 | CA2537292C 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/27/2013 | CN1513849B Mannitol and sorbierite derivative |
| 03/27/2013 | CN103003258A Process for the preparation and isolation of 2-substituted tetrahydropyranols |
| 03/27/2013 | CN102993145A Lovastatin extraction and purification method |
| 03/27/2013 | CN102993144A One-kettle method synthesis process of 4-aminotetrahydropyran |
| 03/27/2013 | CN102010281B Preparation method of alpha-acyloxy ether |
| 03/27/2013 | CN101544526B Method of activating alpha position C-H key of ether compound and application thereof |
| 03/27/2013 | CN101277966B Process for the synthesis of HMG-CoA reductase inhibitors |
| 03/27/2013 | CN101180284B Method for producing tetrahydropyranes from tetrahydropyran-3-ones |
| 03/21/2013 | US20130072696 Catalytic dehydration of alcohols and ethers over a ternary mixed oxide |
| 03/19/2013 | US8399509 Glucopyranoside derivatives |
| 03/13/2013 | CN102964325A Rose oxide and synthetic method thereof |
| 03/13/2013 | CN102964324A Liquid crystal compound with, its composition and application |
| 03/13/2013 | CN102964239A Metallo-beta-lactamase inhibitor |
| 03/13/2013 | CN102964226A Liquid crystal compound containing cyclobutyl and difluoromethylenedioxy connecting radical as well as preparation method and application thereof |
| 03/13/2013 | CN102964196A Preparation method of nitrile compound |
| 03/12/2013 | US8394994 Method for producing of 2-alkyl-2-cycloalken-1-one |
| 03/12/2013 | US8394851 Osmoprotective complexes for prevention of mitochondrial free radical damage related skin aging |
| 03/12/2013 | US8394755 Polyglyceryl compounds and compositions |
| 03/06/2013 | CN102952033A Novel compound, composing method thereof and therapeutic use therefor |
| 03/05/2013 | US8389073 Four-ring liquid crystal compound having tetrahydropyran and 2,2′,3,3′-tetrafluorobiphenyl, liquid crystal composition and liquid crystal display device |
| 02/28/2013 | WO2013028570A2 Meta-substituted biphenyl peripherally restricted faah inhibitors |
| 02/28/2013 | US20130053385 Method of combating and controlling pests |
| 02/28/2013 | US20130047887 Novel multifunctional molecules for dental bonding applications having improved adhesion |
| 02/28/2013 | CA2844812A1 Meta-substituted biphenyl peripherally restricted faah inhibitors |
| 02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2013 | CN102942548A Delta-dodecalactone synthesis method |
| 02/27/2013 | CN102942484A Menthyl formates, and preparation method and application thereof |
| 02/26/2013 | US8383839 Heterocyclidene acetamide derivative |
| 02/26/2013 | US8383786 Pesticidal compositions |
| 02/21/2013 | US20130045951 Novel Nitroso Compounds as Nitroxyl Donors and Methods of Use Thereof |
| 02/21/2013 | US20130045897 Amphiphilic nanoparticle, composition comprising same and method of controlling oil spill using amphiphilic nanoparticle |
| 02/14/2013 | WO2013022919A1 P62-zz chemical inhibitor |